15.12.2012 Views

Registration Document - Pernod Ricard

Registration Document - Pernod Ricard

Registration Document - Pernod Ricard

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ABOUT THE COMPANY AND ITS SHARE CAPITAL 7<br />

Information about share capital<br />

Information about share capital<br />

The conditions under which the bylaws submit changes to the share<br />

capital and the rights attached thereto are compliant in every aspect<br />

with legal stipulations in France. The bylaws do not provide for any<br />

overriding provisions and do not impose any special contingencies.<br />

Amount of paid-up capital<br />

at 30 June 2009<br />

On 7 April 2009, the Board of Directors recorded that on 1 April 2009<br />

the share capital had increased by a nominal amount of €163,693.95<br />

as a result of the exercise of 105,609 stock options, since 1 July 2008,<br />

granting entitlement to the same number of <strong>Pernod</strong> <strong>Ricard</strong> shares.<br />

On 14 May 2009, the Company recorded a cash capital increase<br />

through which 38,786,220 new shares were issued, leading to a capital<br />

increase for the Company for the nominal amount of €60,118,641.<br />

On 22 July 2009, the Board of Directors recorded that on 30 June 2009<br />

the share capital had increased by a nominal amount of €101,886.15<br />

as a result of the exercise of 65,733 stock options, since 14 May 2009,<br />

granting entitlement to the same number of <strong>Pernod</strong> <strong>Ricard</strong> shares.<br />

As a result, <strong>Pernod</strong> <strong>Ricard</strong>’s subscribed and fully paid up share capital<br />

amounted to €400,892,830.80 as of 30 June 2009, divided into<br />

258,640,536 shares with a nominal value of €1.55.<br />

Shares not representing<br />

capital<br />

There are no shares that do not represent the Company’s share<br />

capital.<br />

<strong>Pernod</strong> <strong>Ricard</strong> shares held by Le Delos Invest I, Le Delos Invest II and<br />

Lirix (companies controlled by Société Paul <strong>Ricard</strong> SA, as defined in<br />

article 233-3 of the French Commercial Code) are pledged for third<br />

parties.<br />

<strong>Pernod</strong> <strong>Ricard</strong> shares held by Le Delos Invest III (a company<br />

controlled by Société Paul <strong>Ricard</strong> SA, as defined in article 233-3 of the<br />

French Commercial Code) were transferred as collateral for the good<br />

performance of its obligations under the terms of a prepaid forward<br />

transaction entered into on 10 April 2009.<br />

Financial authorisations<br />

General authorisations<br />

The Combined (Ordinary and Extraordinary) Shareholders’ Meeting<br />

of 7 November 2007 granted the Board of Directors a number of<br />

financial authorisations, for a period of 26 months, in accordance<br />

with article L. 225-129 et seq. of the French Commercial Code, of which<br />

the main terms are outlined below. The purpose of the authorisations<br />

are to allow the Company, if necessary, to increase in due course their<br />

capital either by the capitalisation of reserves, earnings, premiums or<br />

others, or the issue, with or without preferential subscription rights,<br />

of different securities granting access, immediately or in the future,<br />

to <strong>Pernod</strong> <strong>Ricard</strong>’s capital.<br />

The same Meeting also delegated authority to the Board of Directors<br />

to decide, if the expected demand is exceeded at the time of a capital<br />

increase with or without preferential subscription rights, to increase<br />

the shares issued at the same price as that in the initial issue, within<br />

the regulatory periods and limits.<br />

Since the majority of these authorisations expire in January 2010,<br />

at the Shareholders’ Meeting of 2 November 2009 a number of new<br />

financial authorisations will be put to the vote, of which the terms<br />

and conditions are outlined under “Presentation of the resolutions”<br />

in the section “Combined (Ordinary and Extraordinary) Shareholders’<br />

Meeting” in this document.<br />

Securities representing capital<br />

(i) Issues of shares or securities with preferential<br />

subscription rights<br />

The Combined (Ordinary and Extraordinary) Shareholders’ Meeting<br />

of 7 November 2007 authorised the Board of Directors to:<br />

◆ perform one or more capital increases, via the issue of ordinary<br />

shares and/or securities granting access to the share capital, with<br />

preferential subscription rights;<br />

◆ perform one or more capital increases, via the capitalisation of<br />

premiums, reserves, earnings or others.<br />

The maximum nominal amount of capital increases that may be<br />

performed under the aforementioned authorisations was set at<br />

€170 million: this is an overall limit applied to all issues performed<br />

under any of the aforementioned authorisations, as well as any<br />

issue performed with cancellation of preferential rights (it being<br />

specified that the maximum nominal amount of the latter is limited<br />

to €68 million).<br />

If necessary, a supplementary amount will be added to this limit for<br />

shares to be issued, in accordance with the law, to preserve the rights<br />

of holders of securities or rights granting access to share capital.<br />

The maximum nominal amount of debt securities that may be issued<br />

within the scope of the first authorisation, mentioned above, was set<br />

at €5 billion.<br />

(ii) Issues of shares or securities with cancellation<br />

of preferential subscription rights<br />

The Combined (Ordinary and Extraordinary) Shareholders’ Meeting<br />

of 7 November 2007 authorised the Board of Directors to:<br />

◆ carry out one or more capital increases, via the issue of ordinary<br />

shares or securities granting access to share capital with<br />

cancellation of preferential subscription rights, via public offer,<br />

within the limits of a maximum nominal amount of €68 million<br />

(the Board of Directors is bound by legal and regulatory constraints<br />

in terms of the issue price). This amount will be deducted from the<br />

I REFERENCE DOCUMENT 2008/2009 I PERNOD RICARD 185

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!